![]() ![]() |
|
|||||||||
| Greater geometrical precision improving sparing during the treatment of even the smallest tumors in close proximity to normal structures | ![]() |
|
| Hypo-fractionization allows patients to be treated in 1-5 days, compared to 4-6 weeks for conventional radiotherapy | ||
| Higher fractional doses may be more effective in treating radio-resistant cancers |
The latest vendor technologies offer enhanced application of SRS related to: integrated, on-board imaging; non-invasive immobilization; optical guided set up; and the ability to choose between cone and MLC-based treatment approach with one machine. These advancements in technology afford the opportunity to apply the clinical benefits of SRS to extra-cranial sites.
Although the benefits of the latest application of SRS with advanced technology are substantial, clinicians struggle with the learning curve associated with applying the new technology and integrating advanced clinical practice into workflow.
Clinical processes that must be modified include:
While vendor training focuses on the operation of technology, D3 focuses on assisting clinicians with the optimal clinical application to improve quality and efficiency of workflow.
D3 offers an SRS Program with optional ongoing planning and consultative services to enable radiation therapy staff to attain the full benefits of the latest technology. Our services can be customized according to the unique needs of your clinic.
The D3 SRS program prepares the entire clinical team to treat patients with SRS considering the change in clinical processes that are required for physicians, therapists, dosimetrists and physicists.
Services include the following:
|